This indicates that the increase in calpain-2 protein and activity observed in APP/PS1 mice, the mouse model of AD is specifically caused by elevated amyloid beta deposition and is not an artifact of APP overexpression. This evidence concerns the gene CAPN2 and Alzheimer disease.